产品名称
18:1 PEG550 PE, Avanti Research™ - A Croda Brand 880530O
assay
>99% (TLC)
form
liquid
packaging
pkg of 1 × 25 mg (880530O-25mg)
manufacturer/tradename
Avanti Research™ - A Croda Brand 880530O
shipped in
dry ice
storage temp.
−20°C
SMILES string
[H][C@@](COP([O-])(OCCNC(OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)=O)=O)(OC(CCCCCCC/C=C\CCCCCCCC)=O)COC(CCCCCCC/C=C\CCCCCCCC)=O.[NH4+]
InChI
1S/C67H128NO22P.H3N/c1-4-6-8-10-12-14-16-18-20-22-24-26-28-30-32-34-65(69)87-62-64(90-66(70)35-33-31-29-27-25-23-21-19-17-15-13-11-9-7-5-2)63-89-91(72,73)88-37-36-68-67(71)86-61-60-85-59-58-84-57-56-83-55-54-82-53-52-81-51-50-80-49-48-79-47-46-78-45-44-77
InChI key
CVNDAUVVWJSMPS-GJGOCQBBSA-N
General description
18:1 PEG550 PE is a polyethylene glycol (PEG) conjugated phospholipid. PEGylated phospholipids are amphiphilic polymers, The molecular weight and exact mass are averages based on the polydispersity of PEG.
Application
18:1 PEG550 PE is suitable for liposome formation.
Biochem/physiol Actions
18:1 PEG550 PE is known to reduce the random binding of quantum dot tagged proteins to the lipid bilayer in liposomes. Polyethylene glycol (PEG) conjugated phospholipids protect the liposome steriochemistry and are recommended for use in liposome formulation.
Packaging
5 mL Clear Glass Sealed Ampule (880530O-25mg)
Legal Information
Avanti Research is a trademark of Avanti Polar Lipids, LLC
存储类别
10 - Combustible liquids
Kenneth K Y Ho et al.
PloS one, 12(3), e0174689-e0174689 (2017-03-31)
Development of artificial cell models requires encapsulation of biomolecules within membrane-bound compartments. There have been limited studies of using mammalian cell-free expression (CFE) system as the 'cytosol' of artificial cells. We exploit glass capillary droplet microfluidics for the encapsulation of
Brian J Nablo et al.
Biophysical journal, 95(3), 1157-1164 (2008-07-23)
Nonelectrolyte polymers of poly(ethylene glycol) (PEG) were used to estimate the diameter of the ion channel formed by the Bacillus anthracis protective antigen 63 (PA(63)). Based on the ability of different molecular weight PEGs to partition into the pore and
G F Peacock et al.
Drug delivery, 10(1), 29-34 (2003-01-30)
A new cholesterol-carborane conjugate (BCH) has been synthesized as a potential targeting agent for boron neutron capture therapy (BNCT) of cancers. The compound is extremely water insoluble and was formulated in two liposomal formulations to determine if the compound could
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| 880530O-25MG | 04061835192489 |